Quantinno Capital Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.03M Buy
161,975
+12,109
+8% +$283K ﹤0.01% 1415
2026
Q1
$2.1M Sell
149,866
-57
-0% -$768 ﹤0.01% 1593
2025
Q4
$1.68M Buy
149,923
+81,430
+119% +$932K ﹤0.01% 1447
2025
Q3
$792K Buy
68,493
+41,281
+152% +$483K ﹤0.01% 1636
2025
Q2
$333K Buy
27,212
+15,479
+132% +$195K ﹤0.01% 1944
2025
Q1
$168K Buy
+11,733
New +$183K ﹤0.01% 1928
2020
Q4
Sell
-15,368
Closed -$511K 338
2020
Q3
$511K Buy
+15,368
New +$491K 0.34% 107

Other funds holding AVNS

Quantinno Capital Management's AVNS Position: Q2 2026 in Review

Quantinno Capital Management increased its Avanos Medical (AVNS) stake by 8.1% in Q2 2026, buying an estimated $283K and bringing the position to 161,975 shares worth $4.03M. The position accounts for ﹤0.01% of the portfolio, ranked #1415.

Quantinno Capital Management first reported a position in AVNS in Q3 2020 and has held it in 7 quarters since. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Quantinno Capital Management held 161,975 shares of Avanos Medical worth $4.03M as of Q2 2026.
  • Quantinno Capital Management bought 12,109 Avanos Medical shares in Q2 2026, an estimated $283K.
  • Avanos Medical made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #1415 holding.
  • Quantinno Capital Management first reported a position in Avanos Medical in Q3 2020 and has held it in 7 quarters since.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.